• SMA Genetic Carrier Status Test Being Launched in Europe, Latin America
  • Cure SMA to Host May 4 Webinar on Spinraza Access, Insurance Coverage and Trial Results
  • Spinraza Clinical Trial Updates Confirm Treatment Benefits in All SMA Types
  • Updates From Trial of AveXis SMA1 Gene Therapy Trial Show Impressive Results in Most Infants
  • EMA Panel Recommends Approval of Biogen’s Spinraza in Europe
  • Why Can’t Games Like ‘Battlefront’ Be Bit More SMA Friendly?
  • Spinraza’s Benefits to Infants with Type 1 SMA Detailed at AAN Meeting
  • Biogen to Present New Results for Spinraza, Other Treatments for Neurological Diseases
  • Harvard Team Finds Compound to Restore Protein That Is Short in SMA
  • Welcome to ‘Embracing My Inner Alien,’ a Column by Kevin Schaefer
  • Illness Becomes Chronic, But I’m Taking ‘My Shot’
  • Genentech Considering Design of Phase 3 Clinical Trial for SMA Therapy